2025 ICD-10-PCS Procedure Code XW043B3
- Introduction Central Vein to New Technology Group 3 with Cytarabine and Daunorubicin Liposome Antineoplastic, Percutaneous Approach
- ICD-10-PCS XW043B3 is a specific/billable code that can be used to indicate a procedure.
daunorubicin
central
cytarabine
introduction
technology
liposome
percutaneous
| Section | X - New Technology |
| Body System | W - Anatomical Regions |
| Operation | 0 - Introduction - Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| Body Part | 4 - Central Vein |
| Approach | 3 - Percutaneous |
| Device | B - Cytarabine and Daunorubicin Liposome Antineoplastic |
| Qualifier | 3 - New Technology Group 3 |